Knowledge, attitude, practice of rational use of medicines among junior residents in a tertiary care hospital

Hooli Tanuja V., . Srikanth, Somashekara S. C., Suraj B.


Background: Irrational use of prescribing is on the rise due to many factors like false beliefs, following a prescribing pattern of senior doctors, inadequate knowledge, ignorance, promotional activities for the profit of professionals by pharmaceutical industry and lack of enforcement of regulations by regulatory authorities. Junior residents are exposed to variety of prescribing patterns in the first year and are the future physicians and specialists. There are very few studies among JRs, hence the present study was conducted to assess the knowledge, attitude and practice of junior residents about rational use of medicines.

Methods: This was a cross-sectional, questionnaire based study conducted among JRs at a tertiary care hospital in South India in June 2015. The participants were explained about the study and consent was taken. Permission was obtained from institutional ethics committee. Identity of the residents was kept confidential. A self-developed, pre-validated, semi-structured questionnaire consisting of both open-ended and closed-ended items was used. Questionnaire was designed to obtain information about the knowledge, attitude and practice of RUM. The data was recorded and analyzed using Microsoft Excel (2013 version) and the results are explained in frequency and percentage.

Results: The knowledge related to essential medicines list (EML), P drugs and schedule H drugs was limited. Participants had limited knowledge about the revision of EML list, number of fixed dose combinations (FDCs)in EML, STEP criteria for choosing a P drug and advantages of choosing a P drug Most of the JRs frequently prescribed drugs from EML. Trade name and newer drugs were prescribed around 50%. The prescription of FDCs from EML was very low (6%). Around 50% of JRs prescribe medicines with both generic and brand name.

Conclusions: Majority of JRs were aware about various issues concerned with RUM but the knowledge related to EML, P drugs, schedule H drugs and number of FDCs in EML was limited.  As junior residents are future prescribers, they need to be aware of all the aspects of RUM. Inadequate/improper knowledge in the above areas is a matter of concern and needs to be addressed.


Essential medicine list, KAP study, P-drugs, Rational use of medicine

Full Text:



World Health Organization: Guide to Good Prescribing, Geneva. World Health Organization. 1994;101-3.

Holloway K. Promoting rational use of medicines. Contact a publication of world council of churches. 2006;183:2-3.

The Selection of Essential Medicines-Perspectives WHO policies. 2002;1-6.

National list of essential medicines 2015 (India). Available at: Last accessed on 20th December 2016 at 9 pm.

Manikandan S, Gitanjali B. National list of essential medicines of India: The way forward. J Postgr Med. 2012;58(1):68-72.

Patrício KP, Alves NA, Arenales NG, Queluz TT. Teaching the Rational Use of Medicines to medical students: A qualitative research. BMC Med Educ. 2012;12:56.

Toklu HZ, Demirdamar R, Gümüşel B, Ersin YE, Dülger G. Rational drug use awareness of the nurses in the Turkish republic of Northern Cyprus near east university hospital. Marmara Pharmaceutical Journal. 2012;16:150-4.

Kunda G, Thawani V, Sontakke S, Chaudhari K, Bankar M, Diwe R. Effect of information, education and communication intervention on awareness about rational pharmacy practice in pharmacy students. Indian Journal of Pharmacology. 2011;43(4):381-4.

Sankaravadivu T, Kumar SE, Bhavya E. A prospective study on rational drug use and the essential drug concept. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2011;2(2):503-6.

Badran IG. Knowledge, attitude and practice the three pillars of excellence and wisdom: A place in the medical profession. Eastern Mediterranean Health Journal. 1995;1:8-16.

Mahajan R, Singh NR, Singh J, Dixit A, Jain A, Gupta A. Current scenario of attitude and knowledge of physicians about rational prescription: A novel cross-sectional study. J Pharm Bioalln Sci. 2010;2(2):132-6.

Bajait CS, Pimpalkhute SA, Sontakke SD, Dakhale GN, Jaiswal KM, Urade CS. Evaluation of knowledge, attitude and practice of rational use of medicines among clinicians in a tertiary care teaching hospital. Int J Nutr Pharmacol Neurol Dis. 2014;4:153-7.

Dakhale G, Pimpalkhute S, Bajait C, Raghute L. Evaluation of Knowledge, Attitude and Practice of Rational use of Medicine Among Interns and Resident Doctors in a Tertiary Care Teaching Hospital. J Young Pharm. 2016;8(2):114-7.

Hogerzeil HV. The concept of essential medicines: Lessons for rich countries. BMJ. 2004;329:1169‑72.

Rathod R, Rathod A, Gupta VK, Ahmed T, Jha RK, Gaikwad N. Audit in Dermatology for Rational Prescribing. RJPBCS. 2012;3(3):518-24.

Abidi A, Gupta S, Kansal S. Prescription auditing and drug utilization pattern in a tertiary care teaching hospital of western UP. IJBCP. 2012;1(3):184-90.

Use of Generic name of drugs. Available at: Last accessed on 5th May 2017 at 6 pm.

Parmar DM, Jadhav S. The concept of personal drugs in the undergraduate pharmacology practical curriculum. Indian J Pharmacol. 2007;39(3):165-7.

Gwee MC. Teaching of medical pharmacology: the need to nurture the early development of desired attitudes for safe and rational drug prescribing. Med Teach. 2009;31(9):847-54.

Oshikoya KA, Senbanjo IO, Amole OO. Interns knowledge ofclinical pharmacology and therapeutics after undergraduate and ongoinginternship training in Nigeria: a pilot study. BMC Medical Education. 2009;9(1):50.

Rothwell C, Burford B, Morrison J, Morrow G, Allen M, Davies C, et al. Junior doctors prescribing: enhancing their learning in practice. Br J Clin Pharmacol. 2011;73(2):194-202.

De Vries TP, Henning RH, Horgerzeil HV, Fresle HV. World Health Organization: Guide to good prescribing. Geneva: WHO. 1994;14-8.

Maxwell S, Walley T, Ferner R. Using drugs safely. BMJ. 2002;324(7343):930-1.

World Health Organization. The Selection and Use of Essential Medicines‑Report of the WHO Expert Committee. Geneva: WHO; 2011:8-9.